Phocas Financial Corp.

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1356783 ALAMEDA, CA

Position in AMRX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$14,185,129

+$1,722,016 QoQ

Shares Held

819,476

-18.3% QoQ

Ownership

0.257%

of shares outstanding

% of Portfolio

1.98%

of 13F equity value

Holder Rank

#30

of 305 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 16% Shared 0% None 84%

Healthcare · as of Jun 30, 2026

Phocas Financial Corp. holds $23,724,903 across 4 Drug Manufacturers - Specialty & Generic names. AMRX ranks #1 (59.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc. This page	819,476	$14,185,129
2	BCRX	Biocryst Pharmaceuticals Inc	340,541	$3,405,410
3	ELAN	Elanco Animal Health Inc	135,392	$3,331,997
4	SUPN	Supernus Pharmaceuticals, Inc.	60,253	$2,802,367

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,185,129	819,476	-18.3%	Shares	Sole	2026-07-31
2026-03-31	$12,463,113	1,002,664	-21.8%	Shares	Sole	2026-05-01
2025-12-31	$16,165,472	1,282,974	-0.2%	Shares	Sole	2026-01-26
2025-09-30	$12,870,697	1,285,784	+2.1%	Shares	Sole	2025-11-12
2025-06-30	$10,189,872	1,259,564	+0.0%	Shares	Sole	2025-08-06
2025-03-31	$10,553,587	1,259,378	-5.3%	Shares	Sole	2025-05-09
2024-12-31	$10,536,870	1,330,413	+31.1%	Shares	Sole	2025-03-05
2024-09-30	$8,446,380	1,015,190	-5.9%	Shares	Sole	2024-11-07
2024-06-30	$6,849,586	1,078,675	+54.7%	Shares	Sole	2024-07-24
2024-03-31	$4,224,322	697,083	-2.5%	Shares	Sole	2024-05-01
2023-12-31	$4,339,382	714,890	—	Shares	Sole	2024-01-30
No filing history on record for this holder in this stock.